Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding BIB?
Track your performance easily
BIB Price & Analysis
BIB ETF Chart & Stats
Day’s Range― - ―
52-Week Range47.20 - 69.56
Previous Close51.41
VolumeN/A
Average Volume (3M)12.43K
AUM63.17M
NAV50.64
Expense Ratio0.95%
Holdings Count267
Beta1.98
Inception DateApr 07, 2010
Last Dividend Ex-Date
Sep 25, 2024Dividend Yield
(0.98%)Shares Outstanding1,230,000
Standard Deviation0.11
10 Day Avg. Volume4,171,718
30 Day Avg. Volume12,433
Alpha-0.01
ProShares Ultra Nasdaq Biotechnology (BIB) Fund Flow Chart
ProShares Ultra Nasdaq Biotechnology (BIB) 1 year Net Flows: -24M
BIB ETF News
BIB ETF FAQ
What was BIB’s price range in the past 12 months?
BIB lowest ETF price was 47.20 and its highest was 69.56 in the past 12 months.
What is the AUM of BIB?
As of Dec 19, 2024 The AUM of BIB is 63.17M.
Is BIB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does BIB pay dividends?
BIB pays a Annually dividend of 0.152 which represents an annual dividend yield of 0.98%. See more information on BIB dividends here
How many shares outstanding does BIB have?
BIB has 1,230,000 shares outstanding.
Which hedge fund is a major shareholder of BIB?
Currently, no hedge funds are holding shares in BIB
Top 10 Holdings
N/A
15.71%
Gilead Sciences
6.73%
U.S. Dollar
6.37%
Amgen Inc
6.26%
Regeneron Pharmaceuticals
5.90%
Vertex Pharmaceuticals Inc.
5.71%
AstraZeneca
2.96%
Alnylam Pharmaceuticals
2.46%
Illumina
1.68%
Biogen Inc.
1.66%
Total55.43%
ETF Description
ProShares Ultra Nasdaq Biotechnology
BIB provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ.